CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Warner Chilcott (US), LLC v. Teva Pharmaceuticals USA, Inc.

1:15-cv-00761

Overview

Case Number 1:15-cv-00761
Filing Date 2015-08-31
Status Terminated
Termination Date 2017-10-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Qualicaps Co., Ltd. Operating Company

Represented By

3 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Warner Chilcott Company, LLC Operating Company

Represented By

3 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Warner Chilcott (US), LLC Operating Company

Represented By

3 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials 1 proceeding
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 1 U.S. Courts: 2
USPTO PTAB Trial 2016-11-04
IPR2017-00203

Mylan Pharmaceuticals Inc. v. Qualicaps Co., Ltd.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2016-04-01
2:16-cv-00323

Warner Chilcott (US), LLC v. Zydus Pharmaceuticals (USA) Inc.

Asserted Patent
Status: TXED
U.S. District Court 2015-11-09
2:15-cv-01740

Warner Chilcott (US), LLC v. Mylan Pharmaceuticals, Inc.

Asserted Patent
Status: TXED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6649180
Hard capsule formed of cellulose ether film with a specific content of methoxyl and hydroxypropoxyl groups
Filed: 2000-04-13
Issued: 2003-11-18
Expired (Term Ended)
Expires: 2020-04-13

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(16 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1779166.) - filed by Warner Chilcott (US), LLC, Qualicaps Co., Ltd., Warner Chilcott Company, LLC. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(nmb) (Entered: 09/01/2015)

Entry #1 • 2015-08-31
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 09/01/2015)

Entry #2 • 2015-08-31
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/17/2015. Date of Expiration of Patent: 4/13/2020.Thirty Month Stay Deadline: 1/17/2018. (nmb) (Entered: 09/01/2015)

Entry #3 • 2015-08-31
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,649,180;. (nmb) (Entered: 09/01/2015)

Entry #4 • 2015-08-31
1

No Summons Issued. (nmb)

Entry #5 • 2015-08-31
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc